Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.550
-0.010 (-0.64%)
Apr 25, 2025, 11:27 AM EDT - Market open

Biodexa Pharmaceuticals Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-5.73-7.08-7.66-5.46-22.19
Upgrade
Depreciation & Amortization
0.250.280.340.41.22
Upgrade
Other Amortization
000--
Upgrade
Loss (Gain) From Sale of Assets
000.01-0.04-0.23
Upgrade
Asset Writedown & Restructuring Costs
----12.37
Upgrade
Stock-Based Compensation
0.280.030.120.09-0.4
Upgrade
Other Operating Activities
-3.34-0.09-0.6-0.381.49
Upgrade
Change in Accounts Receivable
-5.980.370.01-0.490.49
Upgrade
Change in Accounts Payable
2.24-0.210.36-0.13-2
Upgrade
Change in Other Net Operating Assets
--0.210.16--0.05
Upgrade
Operating Cash Flow
-12.26-6.83-7.05-6.01-9.3
Upgrade
Capital Expenditures
-0.01-0.03-0.06-0.32-0.21
Upgrade
Sale of Property, Plant & Equipment
-00.020.040.14
Upgrade
Sale (Purchase) of Intangibles
-0.77-0.24---
Upgrade
Other Investing Activities
0.180.070.03-2.64
Upgrade
Investing Cash Flow
-0.6-0.27-0.22-0.282.57
Upgrade
Short-Term Debt Issued
0.43----
Upgrade
Long-Term Debt Issued
----0.05
Upgrade
Total Debt Issued
0.43---0.05
Upgrade
Long-Term Debt Repaid
-0.19-0.19-0.18-0.22-6.44
Upgrade
Net Debt Issued (Repaid)
0.25-0.19-0.18-0.22-6.4
Upgrade
Issuance of Common Stock
9.0712.080.3210.0910.79
Upgrade
Other Financing Activities
-0.75-1.67-0.1-1.07-1.31
Upgrade
Financing Cash Flow
8.5610.230.058.813.08
Upgrade
Foreign Exchange Rate Adjustments
----0.010.26
Upgrade
Net Cash Flow
-4.33.14-7.222.51-3.38
Upgrade
Free Cash Flow
-12.27-6.85-7.11-6.33-9.51
Upgrade
Free Cash Flow Margin
--1798.42%-1017.17%-1094.81%-2772.60%
Upgrade
Free Cash Flow Per Share
-24.77-216.94---
Upgrade
Cash Interest Paid
-0.010.020.020.03
Upgrade
Cash Income Tax Paid
-0.13-0.85-0.68-1.16-1.95
Upgrade
Levered Free Cash Flow
-13.150.29-5.32-5.3-7.54
Upgrade
Unlevered Free Cash Flow
-13.040.31-5.28-5.27-7.52
Upgrade
Change in Net Working Capital
7.06-4.450.11.071.39
Upgrade
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q